Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 276–276 | Cite as

Immunosuppressants/methotrexate/vedolizumab

Various toxicities: 5 case reports
Case report
  • 36 Downloads

Reference

  1. Lenti MV, et al. A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study. Digestive and Liver Disease 50: 1299-1304, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1016/j.dld.2018.07.007 - UnitedKingdom

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations